medical-device-investing Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026
medical-device-investing Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth
medical-device-investing Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025
medical-device-investing Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System
medical-device-investing Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care
medical-device-investing Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care
medical-device-investing Accuray to Host Analyst Event at the American Society of Radiation Oncology Meeting on September 29, 2025
Apollo Silver Closes First Tranche of $27.5 Million Private Placement Offering Including $2.355 Million Investment from Insiders
Forge Encounters Coal Seam amid Rising Coal Prices and Completes Resin Injections at La Estrella, Colombia
